Business Context and Reporting Period
This Form 8-K Current Report was filed by Northrop Grumman Corporation on February 1, 2021. The filing discloses a material corporate event regarding a significant capital allocation decision rather than periodic financial results.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or debt levels. The primary financial metric disclosed is the authorization of a $2 billion accelerated share repurchase (ASR) program.
- Transaction Value: $2 billion
- Initial Shares Received: Approximately 5.9 million shares
- Counterparty: Goldman Sachs & Co. LLC
Material Changes
The material change reported is the execution of an ASR agreement. Approximately 5.9 million shares were delivered to the Company on February 2, 2021. The final share count will be determined by the volume-weighted average price of the stock during the transaction term, less a discount, with settlement expected in the second quarter of 2021.
Outlook, Risks, and Contingencies
Settlement Mechanics: At settlement, the final number of shares may be adjusted. Goldman Sachs may be required to deliver additional shares, or the Company may be required to deliver shares or make a cash payment to Goldman Sachs depending on market performance and agreement terms.
Authorization: The transaction was executed under the Company's existing share repurchase authorization.
Investor Verification Checklist
- Verify the final number of shares repurchased upon settlement in Q2 2021.
- Confirm the effective average price per share paid for the $2 billion transaction.
- Review the remaining balance of the Company's total share repurchase authorization.
- Monitor for any cash settlement adjustments required at the end of the ASR term.